CFTR regulatory region interacts with NBD1 predominantly via multiple transient helices

Nature Structural and Molecular Biology

Volumn 14, Issue 8, 2007, Pages 738-745

  Baker, Jennifer M R ^a,b   Hudson, Rhea P ^a   Kanelis, Voula ^a   Choy, Wing Yiu ^b,d   Thibodeau, Patrick H ^c   Thomas, Philip J ^c   Forman Kay, Julie D ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOTIDE BINDING PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CHANNEL GATING; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

BINDING SITES; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; HYDROLYSIS; MODELS, MOLECULAR; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PHOSPHORYLATION; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY;

EID: 34547652267     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb1278     Document Type: Article

References (50)

1. Riordan, J.R. et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066-1072 (1989).
2. Dawson, R.J. & Locher, K.P. Structure of a bacterial multidrug ABC transporter. Nature 443, 180-185 (2006).
3. Ostedgaard, L.S., Baldursson, O., Vermeer, D.W., Welsh, M.J. & Robertson, A.D. A functional R domain from cystic fibrosis transmembrane conductance regulator is predominantly unstructured in solution. Proc. Natl. Acad. Sci. USA 97, 5657-5662 (2000).
4. Dulhanty, A.M. & Riordan, J.R. Phosphorylation by cAMP-dependent protein kinase causes a conformational change in the R domain of the cystic fibrosis transmembrane conductance regulator. Biochemistry 33, 4072-4079 (1994).
5. Smith, P.C. et al. ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. Mol. Cell 10, 139-149 (2002).
6. Lewis, H.A. et al. Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J. 23, 282-293 (2004).
7. Rich, D.P. et al. Regulation of the cystic fibrosis transmembrane conductance regulator Cl- channel by negative charge in the R domain. J. Biol. Chem. 268, 20259-20267 (1993).
8. Chang, X.B. et al. Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites. J. Biol. Chem. 268, 11304-11311 (1993).
9. Cheng, S.H. et al. Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. Cell 66, 1027-1036 (1991).
10. Wilkinson, D.J. et al. CFTR activation: additive effects of stimulatory and inhibitory phosphorylation sites in the R domain. Am. J. Physiol. 273, L127-L133 (1997).
11. Vais, H., Zhang, R. & Reenstra, W.W. Dibasic phosphorylation sites in the R domain of CFTR have stimulatory and inhibitory effects on channel activation. Am. J. Physiol. Cell Physiol. 287, C737-C745 (2004).
12. Baldursson, O., Ostedgaard, L.S., Rokhlina, T., Cotten, J.F. & Welsh, M.J. Cystic fibrosis transmembrane conductance regulator Cl- channels with R domain deletions and translocations show phosphorylation-dependent and -independent activity. J. Biol. Chem. 276, 1904-1910 (2001).
13. Xie, J. et al. A short segment of the R domain of cystic fibrosis transmembrane conductance regulator contains channel stimulatory and inhibitory activities that are separable by sequence modification. J. Biol. Chem. 277, 23019-23027 (2002).
14. Csanady, L. et al. Severed channels probe regulation of gating of cystic fibrosis transmembrane conductance regulator by its cytoplasmic domains. J. Gen. Physiol. 116, 477-500 (2000).
15. Winter, M.C. & Welsh, M.J. Stimulation of CFTR activity by its phosphorylated R domain. Nature 389, 294-296 (1997).
16. Wright, P.E. & Dyson, H.J. Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J. Mol. Biol. 293, 321-331 (1999).
17. Romero, P. et al. Sequence complexity of disordered protein. Proteins 42, 38-48 (2001).
18. Dunker, A.K., Obradovic, Z., Romero, P., Garner, E.C. & Brown, C.J. Intrinsic protein disorder in complete genomes. Genome Inform. Ser. Workshop Genome Inform. 11, 161-171 (2000).
19. Iakoucheva, L.M., Brown, C.J., Lawson, J.D., Obradovic, Z. & Dunker, A.K. Intrinsic disorder in cell-signaling and cancer-associated proteins. J. Mol. Biol. 323, 573-584 (2002).
20. Haynes, C. et al. Intrinsic disorder is a common feature of hub proteins from four eukaryotic interactomes. PLoS Comput. Biol. 2, e100 (2006).
21. Gadsby, D.C. & Nairn, A.C. Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis. Physiol. Rev. 79, S77-S107 (1999).
22. Dyson, H.J. & Wright, P.E. Nuclear magnetic resonance methods for elucidation of structure and dynamics in disordered states. Methods Enzymol. 339, 258-270 (2001).
23. Bienkiewicz, E.A. & Lumb, K.J. Random-coil chemical shifts of phosphorylated amino acids. J. Biomol. NMR 15, 203-206 (1999).
24. Neville, D.C. et al. Evidence for phosphorylation of serine 753 in CFTR using a novel metal-ion affinity resin and matrix-assisted laser desorption mass spectrometry. Protein Sci. 6, 2436-2445 (1997).
25. Townsend, R.R., Lipniunas, P.H., Tulk, B.M. & Verkman, A.S. Identification of protein kinase A phosphorylation sites on NBD1 and R domains of CFTR using electrospray mass spectrometry with selective phosphate ion monitoring. Protein Sci. 5, 1865-1873 (1996).
26. Marsh, J.A., Singh, V.K., Jia, Z. & Forman-Kay, J.D. Sensitivity of secondary structure propensities to sequence differences between alpha and gamma synuclein: implications for fibrillation. Protein Sci. 15, 2795-2804 (2006).
27. Andrew, C.D., Warwicker, J., Jones, G.R. & Doig, A.J. Effect of phosphorylation on alpha-helix stability as a function of position. Biochemistry 41, 1897-1905 (2002).
28. Farrow, N.A. et al. Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry 33, 5984-6003 (1994).
29. Schwalbe, H. et al. Structural and dynamical properties of a denatured protein. Heteronuclear 3D NMR experiments and theoretical simulations of lysozyme in 8 M urea. Biochemistry 36, 8977-8991 (1997).
30. Cohn, J.A., Nairn, A.C., Marino, C.R., Melhus, O. & Kole, J. Characterization of the cystic fibrosis transmembrane conductance regulator in a colonocyte cell line. Proc. Natl. Acad. Sci. USA 89, 2340-2344 (1992).
31. Picciotto, M.R., Cohn, J.A., Bertuzzi, G., Greengard, P. & Nairn, A.C. Phosphorylation of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 267, 12742-12752 (1992).
32. Lewis, H.A. et al. Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure. J. Biol. Chem. 280, 1346-1353 (2005).
33. Thibodeau, P.H., Brautigam, C.A., Machius, M. & Thomas, P.J. Side chain and backbone contributions of Phe508 to CFTR folding. Nat. Struct. Mol. Biol. 12, 10-16 (2005).
34. Csanady, L. et al. Preferential phosphorylation of R-domain Serine 768 dampens activation of CFTR channels by PKA. J. Gen. Physiol. 125, 171-186 (2005).
35. Dyson, H.J. & Wright, P.E. Coupling of folding and binding for unstructured proteins. Curr. Opin. Struct. Biol. 12, 54-60 (2002).
36. Pawson, T. Protein modules and signalling networks. Nature 373, 573-580 (1995).
37. Fuxreiter, M., Simon, I., Friedrich, P. & Tompa, P. Preformed structural elements feature in partner recognition by intrinsically unstructured proteins. J. Mol. Biol. 338, 1015-1026 (2004).
38. Oldfield, C.J. et al. Coupled folding and binding with alpha-helix-forming molecular recognition elements. Biochemistry 44, 12454-12470 (2005).
39. Howell, L.D. et al. Protein kinase A regulates ATP hydrolysis and dimerization by a cystic fibrosis transmembrane conductance regulator (CFTR) domain. Biochem. J. 378, 151-159 (2004).
40. Mense, M. et al. In vivo phosphorylation of CFTR promotes formation of a nucleotide-binding domain heterodimer. EMBO J. 25, 4728-4739 (2006).
41. Csanady, L., Chan, K.W., Nairn, A.C. & Gadsby, D.C. Functional roles of nonconserved structural segments in CFTR's NH2-terminal nucleotide binding domain. J. Gen. Physiol. 125, 43-55 (2005).
42. Ma, J., Zhao, J., Drumm, M.L., Xie, J. & Davis, P.B. Function of the R domain in the cystic fibrosis transmembrane conductance regulator chloride channel. J. Biol. Chem. 272, 28133-28141 (1997).
43. Nash, P. et al. Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature 414, 514-521 (2001).
44. Pufall, M.A. et al. Variable control of Ets-1 DNA binding by multiple phosphates in an unstructured region. Science 309, 142-145 (2005).
45. Naren, A.P. CFTR chloride channel regulation by an interdomain interaction. Science 286, 544-548 (1999).
46. Ko, S.B. et al. Gating of CFTR by the STAS domain of SLC26 transporters. Nat. Cell Biol. 6, 343-350 (2004).
47. Sattler, M., Schleucher, J. & Griesinger, C. Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients. Prog. Nucl. Magn. Reson. Spectrosc. 34, 93-158 (1999).
48. Kanelis, V., Forman-Kay, J.D. & Kay, L.E. Multidimensional NMR methods for protein structure determination. IUBMB Life 52, 291-302 (2001).
49. Delaglio, F. et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277-293 (1995).
50. Johnson, B.A. & Blevins, R.A. NMRView - a computer program for the visualization and analysis of NMR data. J. Biol. NMR 4, 603-614 (1994).